Concepedia

Mikhail V. Kulak

MV

Statistics

Publications

23

Citations

910

H-Index

18

Active since

2007

Affiliations

University of Iowa(Current)

State Research Center of Virology and Biotechnology VECTOR

Center for Biologics Evaluation and Research

Mikhail V. Kulak is an author at University of Iowa specializing in molecular oncology, medicine, and oncology.

ORCID

Publications per year

2007–2021

23

Publications

23

Sumoylation Pathway Is Required to Maintain the Basal Breast Cancer Subtype

Maria V. Bogachek, Yizhen Chen, Mikhail V. Kulak et al. · Cancer Cell · 2014 · 97 citations · Full text

, , +7

Hypoxia perturbs aryl hydrocarbon receptor signaling and CYP1A1 expression induced by PCB 126 in human skin and liver-derived cell lines

Sabine U. Vorrink, Paul Severson, Mikhail V. Kulak et al. · Toxicology and Applied Pharmacology · 2013 · 84 citations

, , +17

Inhibiting the SUMO Pathway Represses the Cancer Stem Cell Population in Breast and Colorectal Carcinomas

Maria V. Bogachek, Jung M. Park, James P. De Andrade et al. · Stem Cell Reports · 2016 · 72 citations · Full text

, , +17

TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesis

Anthony R. Cyr, Mikhail V. Kulak, J M Park et al. · Oncogene · 2014 · 71 citations · Full text

, , +14

Transcriptional regulation of the GPX1 gene by TFAP2C and aberrant CpG methylation in human breast cancer

Mikhail V. Kulak, Anthony R. Cyr, George W. Woodfield et al. · Oncogene · 2012 · 70 citations

, , +17

1–5 of 23